Latest News and Press Releases
Want to stay updated on the latest news?
-
TORONTO, 11 juill. 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), une société chef de file spécialisée dans la biotechnologie en stade clinique qui décode les données biologiques afin...
-
TORONTO, June 26, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today celebrated the opening of its...
-
SALT LAKE CITY, June 13, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the full...
-
SALT LAKE CITY, June 01, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a clinical stage TechBio company decoding biology to industrialize drug discovery, today announced its participation in...
-
SALT LAKE CITY, May 25, 2023 (GLOBE NEWSWIRE) -- Altitude Lab announced today that its incubator program and facility will leave Research Park to grow its operation in the Gateway’s BioHive hub as...
-
SALT LAKE CITY, May 16, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced it has appointed...
-
SALT LAKE CITY y TORONTO y MONTREAL, May 09, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), una empresa líder de tecnobiología en etapa clínica con la decodificación de biología para la...
-
SALT LAKE CITY, TORONTO et MONTRÉAL, 10 mai 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ : RXRX), une société de biotechnologie au stade clinique de premier plan qui décode la biologie pour...
-
SALT LAKE CITY und TORONTO und MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), ein führendes, im klinischen Stadium tätiges TechBio-Unternehmen, das die Biologie...
-
SALT LAKE CITY और TORONTO और MONTRÉAL, May 10, 2023 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), जो कि औषधि की खोज को औद्योगीकृत करने के लिए बाय़ोलॉजी को डिकोड करने वाली एक प्रमुख क्लीनिकल...